| Cat. No. |
Size |
Price |
Figures |
|---|
RP17314-1 mg
| 1 mg | $ 99.00 | MSDS: 20080915230104 (PDF)
STRUCTURE:
Zoom
References:
- Peterson NC, Servinsky MD.et al. Tamoxifen resistance and Her2/neu expression in an aged, irradiated rat breast carcinoma model. Carcinogenesis. Sep 2005;26(9):1542-52.
- Wikman M, Steffen AC et al. Selection and characterization of HER2/neu-binding affibody ligands. Protein Eng Des Sel. May 2004;17(5):455-62.
- Nguyen DM, Desai S et al. Modulation of metastasis phenotypes of non-small cell lung cancer cells by 17-allylamino 17-demethoxy geldanamycin. Ann Thorac Surg. Dec 2000;70(6):1853-60.
|
|---|
| Full Name | |
Sequence
(one-letter code) |
IISAVVGIL | Sequence
(three-letter code) | {ILE}{ILE}{SER}{ALA}{VAL}{VAL}{GLY}{ILE}{LEU} |
|---|
| Description | Affibody (affibody) ligands that are specific for the extracellular domain of human epidermal growth factor receptor 2 (HER2/neu) have been selected by phage display technology from a combinatorial protein library based on the 58 amino acid residue staphylococcal protein A-derived Z domain. |
|---|
| Formula | C42H77N9O11 |
|---|
| M.W. | 884.12 |
|---|
| Purity | > 95% |
|---|
| Storage | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
| * For Non-Clinical Research Use Only * If you cannot find your peptides on our list, try our Express PeptideTM Service, and receive high-quality peptides in eight business days, guaranteed. Our customer service is available 24 hours a day, Monday through Friday. You may contact us any time for assistance. |
|
